Gastro Intestinal Stromal Tumour: Treatment Strategies

Authors

  • Masrur Akbar Khan Medical Officer, Department of Surgery, Dhaka Medical College Hospital, Dhaka

DOI:

https://doi.org/10.3329/jss.v20i2.43817

Keywords:

Gastrointestinal stromal tumour, KIT, platelet derived growth factor receptor, imatinib mesylate

Abstract

Recent discoveries over the last decade have led to a greater insight to the molecular and biologicalbehavior of GIST along with its expression of receptors like KIT and platelet derived growthfactor. Consequently the advent of the tyrosine kinase inhibitor imatinibmesylate has been aphenomenal example of targeted molecular therapy. The unique success of the targeted therapyin the management of GIST has enhanced the multidisciplinary management approach to thedisease. Careful and intense study of the treatment strategies in GIST may lead to new era in themanagement of cancer.

Journal of Surgical Sciences (2016) Vol. 20 (2) :55-58

Downloads

Download data is not yet available.
Abstract
25
PDF
30

Downloads

Published

2019-11-07

How to Cite

Khan, M. A. (2019). Gastro Intestinal Stromal Tumour: Treatment Strategies. Journal of Surgical Sciences, 20(2), 55–58. https://doi.org/10.3329/jss.v20i2.43817

Issue

Vol. 20 No. 2 (2016)

Section

Review Articles

License

No part of the materials published in this Journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Reprints of any article in file Journal will be available from the publisher.